Condensed Balance Sheets - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Current Assets
Cash and Cash Equivalents	$ 32,955	$ 21,799
Prepaid and other current assets	5,000	5,000
Total current assets	37,955	26,799
Patents, net	39,488	0
TOTAL ASSETS	77,443	26,799
Current Liabilities
Accounts payable and accrued expenses	1,014,412	826,486
Accrued liabilities - related parties	138,616	3,207
Accrued litigation settlement	450,000	120,000
Promissory note payable	85,080	0
Loans payable - related parties	404,000	219,000
Total current liabilities	2,092,108	1,168,693
TOTAL LIABILITIES	2,092,108	1,168,693
Commitments and Contingencies	0	0
Stockholders' Equity (Deficit)
Series A Convertible Preferred Stock - $.001 par value, 1,000,000 shares Authorized and 0 shares issued and outstanding	0	0
Common Stock - $.001 par value, 300,000,000 shares Authorized, 228,877,509 and 228,667,229 shares issued at March 31, 2022 and December 31, 2021	228,877	228,667
Additional Paid-In Capital	71,109,164	71,017,881
Accumulated Deficit	(73,352,706)	(72,388,442)
Total Stockholders' Equity (Deficit)	(2,014,665)	(1,141,894)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$ 77,443	$ 26,799